Chu G X, Chen X
Department of Pharmacology, Hu-nan Medical University, Changsha, China.
Zhongguo Yao Li Xue Bao. 1990 Mar;11(2):119-23.
The correlation between protective effect of ginsenosides Rb + R0 and brain endogenously-derived prostacyclin synthesis, thromboxane A2 formation and lipid peroxidation were estimated in rats. Ginsenosides Rb + R0 100 mg/kg iv 30 min before 4-vessel occlusion elevated 6-keto-PGF1 alpha level, declined thromboxane B2 and brain edema formation, reduced the rise of lipid peroxides and suppressed the reduction in both creatine phosphokinase (CK) and superoxide dismutase (SOD) activities in brain tissue after 40-min ischemia followed by 1-h reperfusion. Furthermore, these improvements were partially abolished by pretreating with iv indomethacin. It is concluded that ginsenosides possess protective effect on cerebral ischemia-reperfusion injury of rats and ginsenosides Rb + R0 are the active principles. The underlying mechanism of protection is ascribed partially or mainly to the facilitated synthesis and release of prostacyclin, reduced formation of thromboxane A2 and inhibited generation of free radicals and subsequent lipid peroxidation.
在大鼠中评估了人参皂苷Rb + R0的保护作用与脑内源性前列环素合成、血栓素A2形成及脂质过氧化之间的相关性。在四血管闭塞前30分钟静脉注射100 mg/kg人参皂苷Rb + R0,可提高6-酮-前列腺素F1α水平,降低血栓素B2和脑水肿形成,减少脂质过氧化物的升高,并抑制40分钟缺血后再灌注1小时脑组织中肌酸磷酸激酶(CK)和超氧化物歧化酶(SOD)活性的降低。此外,静脉注射吲哚美辛预处理可部分消除这些改善作用。结论为人参皂苷对大鼠脑缺血再灌注损伤具有保护作用,人参皂苷Rb + R0是其活性成分。保护作用的潜在机制部分或主要归因于前列环素合成和释放的促进、血栓素A2形成的减少以及自由基生成和随后脂质过氧化的抑制。